Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2543713 | Journal of the American Pharmacists Association | 2012 | 9 Pages |
Abstract
We recommend using the MID range based on all patients combined (â0.03 to 0.10) to interpret SF-6D scores. These estimates can be used in conjunction with other measures of efficacy to determine meaningful changes. SF-6D demonstrates potential utility in predicting minimally important improvement or worsening among patients receiving different pharmacologic medications.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Pranav K. (PhD Candidate, Assistant Professor), L. Douglas (Professor), Alex (Medical student), I-Chan (Associate Professor),